Literature DB >> 34668864

Early diagnosis and experimental treatment with fenfluramine via the Investigational New Drug mechanism in a boy with Dravet syndrome and recurrent status epilepticus.

Sara Trowbridge1, Annapurna Poduri1, Heather Olson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34668864      PMCID： PMC8842495          DOI： 10.1684/epd.2021.1345

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN： 1294-9361            Impact factor:   1.819


× No keyword cloud information.
  7 in total

Review 1.  From Genetic Testing to Precision Medicine in Epilepsy.

Authors:  Pasquale Striano; Berge A Minassian
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

Review 2.  The genetics of the epilepsies.

Authors:  Christelle M El Achkar; Heather E Olson; Annapurna Poduri; Phillip L Pearl
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

3.  Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel.

Authors:  Elaine C Wirrell; Linda Laux; Elizabeth Donner; Nathalie Jette; Kelly Knupp; Mary Anne Meskis; Ian Miller; Joseph Sullivan; Michelle Welborn; Anne T Berg
Journal:  Pediatr Neurol       Date:  2017-02-04       Impact factor: 3.372

Review 4.  Identifying mutations in epilepsy genes: Impact on treatment selection.

Authors:  Piero Perucca; Emilio Perucca
Journal:  Epilepsy Res       Date:  2019-03-04       Impact factor: 3.045

Review 5.  Fenfluramine for the Treatment of Dravet Syndrome and Lennox-Gastaut Syndrome.

Authors:  Ganna Balagura; Marta Cacciatore; Eleonora A Grasso; Pasquale Striano; Alberto Verrotti
Journal:  CNS Drugs       Date:  2020-10       Impact factor: 5.749

6.  Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial.

Authors:  Lieven Lagae; Joseph Sullivan; Kelly Knupp; Linda Laux; Tilman Polster; Marina Nikanorova; Orrin Devinsky; J Helen Cross; Renzo Guerrini; Dinesh Talwar; Ian Miller; Gail Farfel; Bradley S Galer; Arnold Gammaitoni; Arun Mistry; Glenn Morrison; Michael Lock; Anupam Agarwal; Wyman W Lai; Berten Ceulemans
Journal:  Lancet       Date:  2019-12-17       Impact factor: 79.321

7.  Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial.

Authors:  Rima Nabbout; Arun Mistry; Sameer Zuberi; Nathalie Villeneuve; Antonio Gil-Nagel; Rocio Sanchez-Carpintero; Ulrich Stephani; Linda Laux; Elaine Wirrell; Kelly Knupp; Catherine Chiron; Gail Farfel; Bradley S Galer; Glenn Morrison; Michael Lock; Anupam Agarwal; Stéphane Auvin
Journal:  JAMA Neurol       Date:  2020-03-01       Impact factor: 18.302
  7 in total
  1 in total

1.  A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication.

Authors:  Adam Strzelczyk; Susanne Schubert-Bast
Journal:  CNS Drugs       Date:  2022-02-14       Impact factor: 5.749
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.